Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

Results 1-10 of 15 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2014Consensus statement on the investigation and management of non-radiographic axial spondyloarthritis (nr-axSpA)Robinson, P.; Bird, P.; Lim, I.; Saad, N.; Schachna, L.; Taylor, A.; Whittle, S.; Brown, M.
2014Vemurafenib in patients with BRAFv⁶⁰⁰ mutated metastatic melanoma: an open-label, multicentre, safety studyLarkin, J.; Del Vecchio, M.; Ascierto, P.; Krajsova, I.; Schachter, J.; Neyns, B.; Espinosa, E.; Garbe, C.; Sileni, V.; Gogas, H.; Miller, W.; Mandalà, M.; Hospers, G.; Arance, A.; Queirolo, P.; Hauschild, A.; Brown, M.; Mitchell, L.; Veronese, L.; Blank, C.
2014The La antigen is over-expressed in lung cancer and is a selective dead cancer cell target for radioimmunotherapy using the la-specific antibody APOMAB®Staudacher, A.; Al-ejeh, F.; Fraser, C.; Darby, J.; Roder, D.; Ruszkiewicz, A.; Manavis, J.; Brown, M.
2014Dose selection, pharmacokinetics, and pharmacodynamics of BRAF inhibitor dabrafenib (GSK2118436)Falchook, G.; Long, G.; Kurzrock, R.; Kim, K.; Arkenau, H.; Brown, M.; Hamid, O.; Infante, J.; Millward, M.; Pavlick, A.; Chin, M.; O'Day, S.; Blackman, S.; Curtis, C.; Lebowitz, P.; Ma, B.; Ouellet, D.; Kefford, R.
2014Postchemotherapy and tumor-selective targeting with the la-specific DAB4 monoclonal antibody relates to apoptotic cell clearanceAl-Ejeh, F.; Staudacher, A.; Smyth, D.; Darby, J.; Denoyer, D.; Tsopelas, C.; Hicks, R.; Brown, M.
2014Gemcitabine and CHK1 inhibition potentiate EGFR-directed radioimmunotherapy against pancreatic ductal adenocarcinomaAl-Ejeh, F.; Pajic, M.; Shi, W.; Kalimutho, M.; Miranda, M.; Nagrial, A.; Chou, A.; Biankin, A.; Grimmond, S.; Brown, M.; Khanna, K.
2014Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activationHsieh, C.; Fei, T.; Chen, Y.; Li, T.; Gao, Y.; Wang, X.; Sun, T.; Sweeney, C.; Lee, G.; Chen, S.; Balk, S.; Liu, X.; Brown, M.; Kantoff, P.
2014MiR-221 promotes the development of androgen independence in prostate cancer cells via downregulation of HECTD2 and RAB1ASun, T.; Wang, X.; He, H.; Sweeney, C.; Liu, S.; Brown, M.; Balk, S.; Lee, G.; Kantoff, P.
2014Could bystander killing contribute significantly to the antitumor activity of brentuximab vedotin given with standard first-line chemotherapy for Hodgkin lymphoma?Brown, M.; Staudacher, A.
2014Utility of temporal artery biopsy samples for genome-wide analysis of giant cell arteritisCremin, K.; Leo, P.; Harris, J.; De Smit, E.; Bradbury, L.; McKelvie, P.; Hill, C.; Brown, M.; Hewitt, A.